VETTRAINO, MARINA ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 772
EU - Europa 417
AS - Asia 175
AF - Africa 50
OC - Oceania 1
SA - Sud America 1
Totale 1.416
Nazione #
US - Stati Uniti d'America 771
GB - Regno Unito 129
CN - Cina 93
IT - Italia 67
SG - Singapore 51
DE - Germania 46
SE - Svezia 43
UA - Ucraina 33
IN - India 25
IE - Irlanda 21
TG - Togo 20
CH - Svizzera 19
RU - Federazione Russa 13
FR - Francia 12
BG - Bulgaria 11
ZA - Sudafrica 10
CI - Costa d'Avorio 9
EE - Estonia 9
NG - Nigeria 8
BE - Belgio 7
NL - Olanda 4
SC - Seychelles 3
JO - Giordania 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
LB - Libano 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.416
Città #
Southend 115
Chandler 101
Fairfield 101
Ashburn 78
Woodbridge 54
Wilmington 49
Singapore 44
Seattle 43
Ann Arbor 36
Santa Clara 36
Houston 32
Cambridge 30
Bologna 29
Princeton 26
Dublin 21
Jacksonville 20
Lomé 20
Bern 19
New York 17
Boardman 12
Padova 11
Sofia 11
Westminster 11
Nanjing 10
Abidjan 9
Jinan 9
Shenyang 9
Abeokuta 8
Brussels 7
Berlin 6
Falls Church 6
Turin 6
Beijing 5
Los Angeles 5
Mülheim 5
San Diego 5
Redmond 4
Haikou 3
Jiaxing 3
Mahé 3
Saint Petersburg 3
San Venanzo 3
Taiyuan 3
Tianjin 3
Amman 2
Amsterdam 2
Baoding 2
Bühl 2
Changsha 2
Des Moines 2
Hebei 2
Milan 2
Nanchang 2
Olalla 2
Pont-Canavese 2
Prineville 2
Quanzhou 2
Shanghai 2
Azor 1
Costa Mesa 1
Dallas 1
Dearborn 1
Edinburgh 1
Florence 1
Fuzhou 1
Guangzhou 1
Hefei 1
Helsinki 1
Istanbul 1
Kemerovo 1
Kuban 1
Kunming 1
Langfang 1
Las Vegas 1
London 1
Madrid 1
New Bedfont 1
Ningbo 1
Norwalk 1
Pasadena 1
Phoenix 1
Pune 1
Qingdao 1
Qinhuangdao 1
Quzhou 1
Riyadh 1
San Juan 1
São Paulo 1
Tallinn 1
Taranto 1
Verona 1
Washington 1
Zhengzhou 1
Totale 1.094
Nome #
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 163
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 155
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 143
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 138
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 129
Human RCAN3 gene expression and cell growth in endothelial cells. 126
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. 123
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 101
null 101
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases 81
null 71
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 64
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 46
Totale 1.441
Categoria #
all - tutte 3.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.548


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 0 41 51 65 57 26 22 9
2020/2021135 42 5 12 17 1 2 0 7 26 5 6 12
2021/2022209 13 1 22 17 26 9 4 15 10 11 51 30
2022/2023326 26 56 5 51 23 27 6 23 56 8 15 30
2023/202490 2 16 5 16 2 33 3 3 2 3 0 5
2024/2025148 14 25 17 26 53 13 0 0 0 0 0 0
Totale 1.441